The novel reversible LSD1 inhibitor SP-2577 promotes anti-tumor immunity in SWItch/Sucrose-NonFermentable (SWI/SNF) complex mutated ovarian cancer

标题
The novel reversible LSD1 inhibitor SP-2577 promotes anti-tumor immunity in SWItch/Sucrose-NonFermentable (SWI/SNF) complex mutated ovarian cancer
作者
关键词
Organoids, Cancer treatment, Renal cancer, Lymphocytes, Cancers and neoplasms, T cells, Breast cancer, Ovarian cancer
出版物
PLoS One
Volume 15, Issue 7, Pages e0235705
出版商
Public Library of Science (PLoS)
发表日期
2020-07-11
DOI
10.1371/journal.pone.0235705

向作者/读者发起求助以获取更多资源

Reprint

联系作者

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started